French SPAC Raises $156M To Support Drug Development
Health care-focused special-purpose acquisition company eureKING listed Thursday on Euronext Paris after raising $156 million, money that will potentially fund the acquisition of companies that make medicines for the biotechnology and...To view the full article, register now.
Already a subscriber? Click here to view full article